Optimize Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Buy
1,643
+101
+7% +$27.3K 0.22% 158
2025
Q4
$387K Buy
1,542
+20
+1% +$5.31K 0.19% 218
2025
Q3
$437K Buy
+1,522
New +$408K 0.23% 171

Other funds holding LH

Optimize Financial's LH Position: Q1 2026 in Review

Optimize Financial increased its Labcorp (LH) stake by 6.5% in Q1 2026, buying an estimated $27.3K and bringing the position to 1,643 shares worth $438K. The position accounts for 0.22% of the portfolio, ranked #158.

Optimize Financial first reported a position in LH in Q3 2025 and has held it in 3 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Optimize Financial held 1,643 shares of Labcorp worth $438K as of Q1 2026.
  • Optimize Financial bought 101 Labcorp shares in Q1 2026, an estimated $27.3K.
  • Labcorp made up 0.22% of Optimize Financial's portfolio in Q1 2026, its #158 holding.
  • Optimize Financial first reported a position in Labcorp in Q3 2025 and has held it in 3 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Optimize Financial's 13F filing for Q1 2026, filed 12 May 2026.